Force Therapeutics, headquartered in New York, primarily assists patient rehabilitation through an online platform. According to filings with the U.S. Securities and Exchange Commission, the company has secured an additional $2.6 million in venture capital funding. Previously, in February 2015, it raised $2.2 million in venture capital. To date, the company’s total fundraising amounts to $4.8 million.
The company’s investors include Thomas Layton, former CEO of OpenTable, and John Pleasants, former CEO of Revolution Health and Ticketmaster.

Establishing a Doctor-Patient Communication Platform
In the United States, 50% of adults suffer from musculoskeletal disorders. On Force Therapeutics, the platform provides patients with the various devices they need to facilitate better recovery. Additionally, the platform offers features such as video guidance, patient-provider communication, data collection, and real-time tracking, ensuring that accurate information is delivered in the right way at the right time, thereby bridging the gap between patients and healthcare providers.
Force Therapeutics has developed web-based and mobile applications, creating a platform that connects patients with healthcare providers such as surgeons, internists, and therapists. Patients with musculoskeletal injuries, including arthritis, can access professional diagnostic services and rehabilitation training through the platform when undergoing rehabilitative care.
The app is named Force Patient, with versions available for both iOS and Android. It provides patients with rehabilitation training videos to facilitate home-based rehabilitation. Additionally, the app allows users to track patient progress, access educational materials on rehabilitation, view recommended equipment for purchase, and receive messages from their medical team. Healthcare providers, such as physicians, have a corresponding app called Force Provider, which enables them to monitor patients’ rehabilitation status and training performance.
Gathering Hospitals to Better Serve Patients
The company is currently focused on helping hospitals participate in a new payment bundling initiative under the Content Management System (CMS), specifically the Comprehensive Care for Joint Replacement (CJR) model. Launched this April, the program has enrolled approximately 800 hospitals across the 67 largest metropolitan areas in the United States.
CMS describes the Comprehensive Care for Joint Replacement (CJR) model as follows: By participating in the CJR program, member hospitals can reduce financial expenditures and improve the quality of financial management. Most importantly, this platform connects a large number of hospitals, creating opportunities for collaboration among hospitals and physicians. Upon enrollment, patients with severe joint injuries or complications can benefit from various treatment discounts at these hospitals, along with a 90-day targeted rehabilitation program to facilitate better recovery.
Bronwyn Spira, CEO and co-founder of Force Therapeutics, is a physical therapist. The company’s president, Mark Lieberman, previously worked at Merck and the pharmaceutical company ImClone Systems.